DESMOND Foundation Study - A randomised controlled trial of the DESMOND Foundation Programme for people with established type 2 diabetes in a multi-ethnic population in Leicester and South Birmingham

Principal Investigator: Professor Melanie Davies

Other key staff: Professor Kamlesh Khunti, Dr Sharad Taheri, Dr Emer Brady, Dr Marian Carey, Dr Helen Dallosso, Mrs Heather Daly, Dr Helen Eborall Dr Laura Gray, Dr Sheila Greenfield Dr Karla Hemming, Mrs Lorraine Martin-Stacey, Dr Parth Narendran, Dr Sabi Redwood, Dr Margaret Stone

Partners involved: Birmingham and Black Country CLAHRC, University Hospitals of Leicester NHS Trust, NHS Leicester City PCT, NHS South Birmingham PCT, University of Leicester, University of Birmingham

Summary: Type 2 diabetes is a serious, progressive long-term condition affecting over 2.5 million people in England and when not managed well, can result in blindness, kidney damage, foot ulceration and amputation. Furthermore, it is often associated with complications, which together with chronic high blood glucose levels and additional risk factors increase the risk of stroke, myocardial infarction, peripheral vascular disease and death. The prevalence is greatly increased in certain black and minority ethnic (BME) populations.

The DESMOND Newly Diagnosed programme fulfils national standards for structured education and has been shown to be effective in the newly diagnosed population (Davies et al, 2007). DESMOND programmes have now been developed for the South Asian population (DESMOND BME) and for those who have had diabetes for some time (DESMOND Foundation).

The present study will test the effectiveness of the DESMOND Foundation programme in a multi-ethnic population with established type 2 diabetes. We aim to recruit 640 patients from 16 practices (320 from eight practices in each site). Participants in the intervention arm will attend a DESMOND Foundation Programme delivered in either English or a South Asian language (Gujarati, Urdu or Punjabi). Follow-up will be at six and 12 months.

Further information: If you would like to be involved in this study, or for more information, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Start date: 07/2010                                                                                                                             End date:  06/2012

Aims:

• To test the effectiveness of the DESMOND Foundation programme in a multi-ethnic population with established Type 2 diabetes

Study outcomes:

• The primary outcome is change in HbA1c
•  Secondary outcomes include biomedical, lifestyle and psychological variables